Search Results 921-930 of 17096 for monoclonal antibody

  1. Creation of PLACENTA/Serum Repository Database: Autoimmunity from Mother To Baby Study - Mayo Clinic

    The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research ...

  2. Cross-Variant Memory B Cell and T Cell Responses After COVID-19 mRNA Vaccine Booster - Mayo Clinic

    Receipt of any COVID-19-specific monoclonal antibodies within the past 90 days prior to enrollment. Any acute illness within the last 30 days. Blood ...

  3. Trial to Assess Safety and Effectiveness of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) - Mayo Clinic

    ... antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory). Participation ...

  4. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  5. High blood protein Causes - Mayo Clinic

    https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).

  6. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    ... monoclonal antibodies, antibody drug conjugates, radioimmunoconjugates, or T-cell orother cell-based therapies: 4 weeks (2 weeks permissible before the ...

  7. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

    Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic ...

  8. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis - Mayo Clinic

    History of Grade ≥ 3 infusion-associated AEs or hypersensitivity to another monoclonal antibody, or known hypersensitivity to diphenhydramine or acetaminophen ...

  9. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

    Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or who has not recovered (i.e., ≤ Grade 1 or at baseline) from ...

  10. A Study to Assess the Culture, PCR, Serology and Symptoms of COVID-19 - Mayo Clinic

    Consent waived. Topic 6 - Isolation of human peripheral blood mononuclear cells (PBMC) for development of human monoclonal antibodies, and investigation of HLA ...